These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8510808)

  • 1. Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.
    Biró E; Sarnyai Z; Penke B; Szabó G; Telegdy G
    Neuroendocrinology; 1993; 57(2):340-5. PubMed ID: 8510808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral effects to alpha-melanocyte-stimulating hormone.
    Vecsernyés M; Biró E; Gardi J; Julesz J; Telegdy G
    Endocr Res; 2000 Aug; 26(3):347-56. PubMed ID: 11019900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats.
    Sarnyai Z; Bíró E; Penke B; Telegdy G
    Brain Res; 1992 Aug; 589(1):154-6. PubMed ID: 1330207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.
    Kupferschmidt DA; Newman AE; Boonstra R; Erb S
    Neuroscience; 2012 Mar; 204():125-33. PubMed ID: 21784132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.
    Jahn H; Montkowski A; Knaudt K; Ströhle A; Kiefer F; Schick M; Wiedemann K
    Brain Res; 2001 Mar; 893(1-2):21-8. PubMed ID: 11222988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in rats.
    Biró E; Penke B; Telegdy G
    Neuropeptides; 1997 Jun; 31(3):281-5. PubMed ID: 9243526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
    Basso AM; Spina M; Rivier J; Vale W; Koob GF
    Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
    Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor.
    DeVries AC; Pert A
    Psychopharmacology (Berl); 1998 Jun; 137(4):333-40. PubMed ID: 9676892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
    Korte SM; Korte-Bouws GA; Bohus B; Koob GF
    Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor.
    Shepard JD; Myers DA
    Behav Brain Res; 2008 Jan; 186(2):239-45. PubMed ID: 17904655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of CRF- and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat.
    Gué M; Gleïzes-Escala C; Del Rio-Lacheze C; Junien JL; Buéno L
    Br J Pharmacol; 1994 Mar; 111(3):930-4. PubMed ID: 7912631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosterone response to the serotonergic agonist D-fenfluramine may be independent from corticotropin-releasing factor (CRF).
    Baudrie V; Oliver C; Chaouloff F
    Neurosci Lett; 1993 Jun; 156(1-2):121-4. PubMed ID: 8414172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
    Garrido MM; Martin S; Ambrosio E; Fuentes JA; Manzanares J
    Neuroendocrinology; 1998 Aug; 68(2):116-22. PubMed ID: 9705578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.